Prime Capital Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.88 Billion
- Q3 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 24,831 shares of GILD stock, worth $2.27 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,831
Previous 39,739
37.51%
Holding current value
$2.27 Million
Previous $2.73 Million
23.66%
% of portfolio
0.03%
Previous 0.04%
Shares
25 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.99 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.65 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.5 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $114B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...